Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Biliary Tract Neoplasms × Carboplatin × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 200 Lung Neoplasms 89 Ovarian Neoplasms 76 Breast Neoplasms 66 Fallopian Tube Neoplasms 47 Small Cell Lung Carcinoma 39 Neoplasms 38 Triple Negative Breast Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 25 Parkinson Disease 4, Autosomal Dominant Lewy Body 22 Adenocarcinoma of Lung 22 Head and Neck Neoplasms 21 Carcinoma 21 Neoplasm Metastasis 17 Carcinoma, Ovarian Epithelial 16 Brain Neoplasms 14 Carcinoma, Squamous Cell 13 Recurrence 11 Prostatic Neoplasms 11 Melanoma 11 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma 10 Esophageal Neoplasms 10 Endometrial Neoplasms 10 Brenner Tumor 10 Adenocarcinoma, Bronchiolo-Alveolar 10 Urinary Bladder Neoplasms 9 Hodgkin Disease 9 Central Nervous System Neoplasms 8 Carcinoma, Transitional Cell 8

Interventions

Gemcitabine 14 Cisplatin 10 Nivolumab 6 pembrolizumab 4 Oxaliplatin 4 Capecitabine 4 trametinib 3 tremelimumab 2 lenvatinib 2 durvalumab 2 derazantinib 2 atezolizumab 2 Ramucirumab 2 Radiofrequency Ablation 2 Fluorouracil 2 Cryosurgery 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tocilizumab 1 telotristat ethyl 1 sargramostim 1 rucaparib 1 regorafenib 1 pertuzumab 1 merestinib 1 irinotecan sucrosofate 1 devimistat 1 dabrafenib 1 cytokine inducible SH2-containing protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡